Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market
Holding CGTX?
Track your performance easily

Cognition Therapeutics (CGTX) Financial Statements

136 Followers

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.933; its P/E ratio is -0.64; Cognition Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.04M$ -14.05M$ -8.13M$ -14.43M$ -4.72M
EBITDA$ -6.97M$ -13.99M$ -8.07M$ -14.37M$ -4.66M
Net Income Common Stockholders$ -14.35M$ -9.15M$ -8.14M$ -14.43M$ -4.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 28.53M$ 34.67M$ 29.92M$ 32.97M$ 37.19M
Total Assets$ 34.37M$ 38.85M$ 35.16M$ 38.77M$ 43.96M
Total Debt$ 624.00K$ 668.00K$ 694.00K$ 735.00K$ 774.00K
Net Debt$ -27.91M$ -34.00M$ -29.23M$ -32.23M$ -36.42M
Total Liabilities$ 11.36M$ 9.99M$ 10.69M$ 9.85M$ 9.57M
Stockholders Equity$ 23.01M$ 28.86M$ 24.47M$ 28.93M$ 34.39M
Cash Flow-
Free Cash Flow$ -6.00M$ -7.24M$ -5.49M$ -4.22M$ -3.71M
Operating Cash Flow$ -6.00M$ -7.24M$ -5.46M$ -4.16M$ -3.70M
Investing Cash Flow$ -3.00K-$ -30.00K$ -58.00K$ -18.00K
Financing Cash Flow$ -138.00K$ 11.99M$ 2.44M$ -3.00K$ 2.10M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Cognition Therapeutics Debt to Assets

Cognition Therapeutics Cash Flow

Cognition Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis